Click here to view online. Add this email to your safelist.

AstraZeneca logo

Update following statement by NIAID on AZD1222 US Phase III trial data

23 March 2021

The numbers published yesterday were based on a pre-specified interim analysis with a data cut-off of 17 February.

Read more  Read more

RSS Feed  RSS Feed Twitter  Follow us on Twitter LinkedIn  Follow us on LinkedIn
Legal notice and Terms of Use Privacy policy Cookie policy Site map © AstraZeneca 2021

For more information please visit astrazeneca.com.

If you would like to unsubscribe please click here.